Increased CTH (Cystathionine Gamma-Lyase) expression in patients with advanced prostate cancer is associated with poor survival, and H2S produced by CTH promotes the progression and metastasis of prostate cancer through the IL-1β/NF-κB signaling pathway (40). Here, IL1B is linked to prostate carcinoma.